Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis Farhat Nasim11 Oct 2019 9:30 AM ISTNew Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter Medical Dialogues Bureau16 Aug 2019 9:30 AM ISTMumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab Medical Dialogues Bureau28 Jun 2019 12:30 PM ISTThe initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...